{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:00:35Z","timestamp":1776099635407,"version":"3.50.1"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004388","name":"Cephalon","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004388","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.neuropharm.2012.06.036","type":"journal-article","created":{"date-parts":[[2012,7,2]],"date-time":"2012-07-02T08:30:36Z","timestamp":1341217836000},"page":"380-388","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Association of a deficit of arousal with fatigue in multiple sclerosis: Effect of modafinil"],"prefix":"10.1016","volume":"64","author":[{"given":"Graham","family":"Niepel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashid H.","family":"Bibani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janek","family":"Vilisaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Langley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elemer","family":"Szabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cris S.","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.06.036_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/026988119701100110","article-title":"Effects of clonidine and diazepam on the acoustic startle response and on its inhibition by \u2018prepulses\u2019 in man","volume":"11","author":"Abduljawad","year":"1997","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib2","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1177\/1352458509105383","article-title":"Fatigued patients with multiple sclerosis have impaired central muscle activation","volume":"15","author":"Andreasen","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/archneur.61.4.525","article-title":"The relationship of sleep disturbances and fatigue in multiple sclerosis","volume":"61","author":"Attarian","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1191\/1352458503ms904oa","article-title":"Fatigue associated with multiple sclerosis: diagnosis, impact and management","volume":"9","author":"Bakshi","year":"2003","journal-title":"Mult. Scler."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/135245850000600308","article-title":"Fatigue in multiple sclerosis and its relationship to depression and neurologic disability","volume":"6","author":"Bakshi","year":"2000","journal-title":"Mult. Scler."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4088\/JCP.v67n0406","article-title":"A\u00a0systematic review of modafinil: potential clinical uses and mechanisms of action","volume":"67","author":"Ballon","year":"2006","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib7","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1207\/s15327752jpa6703_13","article-title":"Comparison of Beck depression Inventories-IA and -II in psychiatric outpatients","volume":"67","author":"Beck","year":"1996","journal-title":"J.\u00a0Personality Assess."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/01.wco.0000073928.19076.84","article-title":"Cognitive dysfunction in multiple sclerosis: a review of recent developments","volume":"16","author":"Bobholz","year":"2003","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.2044-8341.1974.tb02285.x","article-title":"The use of analogue scales in rating subjective feelings","volume":"47","author":"Bond","year":"1974","journal-title":"Brit. J. Med. Psychol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib10","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/sleep\/33.8.1061","article-title":"Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment","volume":"33","author":"Braley","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.smrv.2009.07.005","article-title":"Sleep disorders in patients with multiple sclerosis","volume":"14","author":"Brass","year":"2010","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000232927","article-title":"Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients","volume":"62","author":"Brioschi","year":"2009","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib13","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1111\/j.1460-9568.2005.04121.x","article-title":"Dopaminergic regulation of orexin neurons","volume":"21","author":"Bubser","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib14","first-page":"174","article-title":"Physiopathology and treatment of fatigue in multiple sclerosis","volume":"248","author":"Comi","year":"2001","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jns.2011.04.024","article-title":"Orexin A (hypocretin-1) levels are not reduced while cocaine\/amphetamine regulated transcript levels are increased in the cerebrospinal fluid of patients with multiple sclerosis: no correlation with fatigue and sleepiness","volume":"307","author":"Constantinescu","year":"2011","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib16","first-page":"485","article-title":"Tiredness versus sleepiness: semantics or a target for public education?","volume":"26","author":"Dement","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0006-8993(86)91016-4","article-title":"Activation of the locus coeruleus induced by selective stimulation of the ventral tegmental area","volume":"363","author":"Deutch","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.880180206","article-title":"Sympathetic skin response (SSR) is abnormal in multiple sclerosis","volume":"18","author":"Elie","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib19","series-title":"Autonomic Failure. A Textbook of Clinical Disorders of the Autonomic Nervous System","first-page":"667","article-title":"Analysis of heart rate variability and other non-invasive tests with special reference to diabetes mellitus","author":"Ewing","year":"1992"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib20","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0006-3223(97)00353-3","article-title":"Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers","volume":"42","author":"Ferraro","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib21","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/clinids\/18.Supplement_1.S79","article-title":"Measuring the functional impact of fatigue: initial validation of the fatigue impact scale","volume":"8","author":"Fisk","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1023\/A:1015295106602","article-title":"Construction and validation of a fatigue impact scale for daily administration (D-FIS)","volume":"11","author":"Fisk","year":"2002","journal-title":"Qual. of Life Res."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1191\/1352458502ms839oa","article-title":"Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters","volume":"8","author":"Flachenecker","year":"2002","journal-title":"Mult. Scler."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib24","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1212\/01.WNL.0000080365.95436.B8","article-title":"Fatigue in MS is related to sympathetic vasomotor dysfunction","volume":"61","author":"Flachenecker","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/ana.1119","article-title":"Nigrostriatal collaterals to thalamus degenerate in parkinsonian animal models","volume":"50","author":"Freeman","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib26","first-page":"349","article-title":"Mechanisms of modafinil: a review of current research","volume":"3","author":"Gerrard","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib27","series-title":"Companion to Psychiatric Studies","first-page":"399","article-title":"Mood disorder","author":"Goodwin","year":"1998"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2012.06.036_bib28","first-page":"I3","article-title":"Autonomic dysfunction in multiple sclerosis","volume":"253","author":"Haensch","year":"2006","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2125.1980.tb01745.x","article-title":"Psychomotor function and psychoactive drugs","volume":"10","author":"Hindmarch","year":"1980","journal-title":"Brit. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1469-8986.1973.tb00801.x","article-title":"Quantification of sleepiness: a new approach","volume":"10","author":"Hoddes","year":"1973","journal-title":"Psychophysiology"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib31","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00213-005-0013-8","article-title":"Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and autonomic functions in human volunteers","volume":"181","author":"Hou","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib32","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/0269881106071022","article-title":"Comparison of diphenhydramine and modafinil on arousal and autonomic functions in healthy volunteers","volume":"21","author":"Hou","year":"2007","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neulet.2010.08.005","article-title":"Modafinil activates the histaminergic system through the orexinergic neurons","volume":"483","author":"Ishikuza","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/B978-0-12-394623-2.00014-7","article-title":"Action of modafinil through histaminergic and orexinergic neurons","volume":"89","author":"Ishikuza","year":"2012","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3940(03)00006-5","article-title":"Modafinil increases histamine release in the anterior hypothalamus of rats","volume":"339","author":"Ishikuza","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-510X(02)00312-X","article-title":"Quality of life in patients with multiple sclerosis: the impact of fatigue and depression","volume":"205","author":"Janardhan","year":"2002","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib37","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A\u00a0new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jns.2010.12.008","article-title":"Sleep disorders and fatigue in multiple sclerosis: evidence for association and interaction","volume":"302","author":"Kaminska","year":"2011","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib39","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1468-1331.2006.01499.x","article-title":"Fatigue and sleep disturbance in multiple sclerosis","volume":"13","author":"Kaynak","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib40","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneur.1988.00520280085020","article-title":"Fatigue in multiple sclerosis","volume":"45","author":"Krupp","year":"1988","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib41","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib42","first-page":"645","article-title":"Modafinil effects in multiple sclerosis patients with fatigue","volume":"256","author":"Lange","year":"2009","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib43","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10072-008-0950-1","article-title":"Physiopathology of fatigue in multiple sclerosis","volume":"29","author":"Leocani","year":"2008","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib44","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00018-011-0631-8","article-title":"The waking brain: an update","volume":"68","author":"Lin","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clineuro.2009.09.004","article-title":"Modafinil for multiple sclerosis fatigue: does it work?","volume":"112","author":"Littleton","year":"2010","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib46","first-page":"138","article-title":"Pupillary movements during acute and chronic fatigue","volume":"2","author":"Lowenstein","year":"1963","journal-title":"Invest. Ophthalmol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1523\/JNEUROSCI.2244-05.2006","article-title":"Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter","volume":"26","author":"Lu","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib48","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey. National multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib49","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/S0042-6989(98)00081-9","article-title":"Mathematical procedures in data recording and processing of pupillary fatigue waves","volume":"38","author":"L\u00fcdtke","year":"1998","journal-title":"Vis. Res."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib50","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pmr.2005.01.014","article-title":"Multiple sclerosis-related fatigue","volume":"16","author":"MacAllister","year":"2005","journal-title":"Phys. Med. Rehab. Clinics North America"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib51","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/jpet.106.106583","article-title":"Modafinil occupies dopamine and norepinephrine transporters in\u00a0vivo and modulates the transporters and trace amine activity in\u00a0vitro","volume":"319","author":"Madras","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib53","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-510X(03)00205-3","article-title":"Autonomic nervous system function in multiple sclerosis","volume":"215","author":"McDougall","year":"2003","journal-title":"J.\u00a0Neurol. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2012.06.036_bib54","first-page":"I21","article-title":"Multiple sclerosis and the autonomic nervous system","volume":"253","author":"Merkelbach","year":"2006","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib55","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1477-7525-8-22","article-title":"Development of a patient reported outcome scale for fatigue in multiple sclerosis: the neurological fatigue index (NFI-MS)","volume":"8","author":"Mills","year":"2010","journal-title":"Health Quality Life Outcomes"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib56","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.npp.1301534","article-title":"Modafinil: a review of neurochemical actions and effects on cognition","volume":"33","author":"Minzenberg","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib57","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1126\/science.1164908","article-title":"Modafinil shifts human locus coeruleus to low-tonic, high-phasic activity during functional MRI","volume":"322","author":"Minzenberg","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib58","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1177\/1352458511402410","article-title":"HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis","volume":"17","author":"M\u00f6ller","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jocn.2005.10.008","article-title":"P300 and treatment effect of modafinil on fatigue in multiple sclerosis","volume":"14","author":"Nagels","year":"2007","journal-title":"J.\u00a0Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib60","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/qjmed\/hcm057","article-title":"Symptoms of autonomic dysfunction in chronic fatigue syndrome","volume":"100","author":"Newton","year":"2007","journal-title":"QJM"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib61","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ajo.2006.04.051","article-title":"Utility of the National Eye Institute VFQ-25 questionnaire in a heterogeneous group of multiple sclerosis patients","volume":"142","author":"Noble","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib62","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0028-3908(71)90039-6","article-title":"The action of sedatives on brain stem oculomotor systems in man","volume":"10","author":"Norris","year":"1971","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib63","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/awq362","article-title":"Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"134","author":"Polak","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib64","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/archneur.61.2.176","article-title":"Fatigue in multiple sclerosis: is the picture getting simpler or more complex?","volume":"61","author":"Racke","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib65","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/jnnp.72.2.179","article-title":"Efficacy and safety of modafinil (Provigil\u00ae) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study","volume":"72","author":"Rammohan","year":"2002","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7224\/1537-2073-6.1.9","article-title":"Cognitive function in patients with multiple sclerosis: impairment and treatment","volume":"1","author":"Rao","year":"2004","journal-title":"Int. J. MS Care"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib67","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00003088-200342020-00002","article-title":"Clinical pharmacokinetic profile of modafinil","volume":"42","author":"Robertson","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib68","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1038\/sj.npp.1301363","article-title":"Modulation of the acoustic startle response by the level of arousal: comparison of clonidine and modafinil in healthy volunteers","volume":"32","author":"Samuels","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib69","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/157015908785777193","article-title":"Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function. Part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans","volume":"6","author":"Samuels","year":"2008","journal-title":"Curr. Neuropharmacol"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib70","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10286-005-0274-7","article-title":"Abnormal heart rate and blood pressure responses to baroreflex stimulation in multiple sclerosis","volume":"15","author":"Sanya","year":"2005","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib71","first-page":"11","article-title":"Modafinil: a drug in search of a mechanism","volume":"27","author":"Saper","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib72","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0022-3999(93)90104-N","article-title":"The measurement of fatigue: a new instrument","volume":"37","author":"Schwartz","year":"1993","journal-title":"J.\u00a0Psychosom. Res."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib73","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00735818","article-title":"Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects. A review","volume":"47","author":"Smith","year":"1976","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib74","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1212\/01.WNL.0000158272.27070.6A","article-title":"Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study","volume":"64","author":"Stankoff","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib75","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1365-2125.2006.02680.x","article-title":"Drugs for sleep disorders: mechanisms and therapeutic prospects","volume":"61","author":"Szabadi","year":"2006","journal-title":"Brit. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2012.06.036_bib76","first-page":"A33","article-title":"Effects of modafinil on measures of alertness and psychomotor functions in multiple sclerosis","volume":"22","author":"Szabadi","year":"2008","journal-title":"J.\u00a0Psychopharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2012.06.036_bib77","first-page":"A59","article-title":"Effects of modafinil on autonomic functions in multiple sclerosis","volume":"23","author":"Szabadi","year":"2009","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib78","series-title":"Sleep Disorders: Diagnostics and Therapeutics","first-page":"281","article-title":"Stimulants: mechanisms and therapeutic prospects","author":"Szabadi","year":"2008"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib79","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/01.HYP.0000158267.66763.63","article-title":"Modafinil elicits sympathomedullary activation","volume":"45","author":"Taneja","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib80","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archneur.61.2.201","article-title":"The relationship between diffuse axonal damage and fatigue in multiple sclerosis","volume":"61","author":"Tartaglia","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib81","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00234-007-0304-3","article-title":"The basal ganglia: a substrate for fatigue in multiple sclerosis","volume":"50","author":"T\u00e9llez","year":"2008","journal-title":"Neuroradiology"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib82","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jama.2009.351","article-title":"Effectsmodafinil on dopamine and dopamine transporters in the male human brain","volume":"301","author":"Volkow","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib83","series-title":"Autonomic Failure. A Textbook of Clinical Disorders of the Autonomic Nervous System","first-page":"359","article-title":"Intraneural recordings of normal and abnormal sympathetic activity in man","author":"Wallin","year":"1992"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7224\/1537-2073-10.1.1","article-title":"Treatment of multiple Sclerosis-related cognitive problems with adjunctive modafinil. Rationale and preliminary supportive data","volume":"10","author":"Wilken","year":"2008","journal-title":"Int. J. MS Care"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib85","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1523\/JNEUROSCI.21-05-01787.2001","article-title":"Dopaminergic role in stimulant-induced wakefulness","volume":"21","author":"Wisor","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib86","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/cne.20859","article-title":"Afferents to the orexin neurons of the rat brain","volume":"494","author":"Yoshida","year":"2006","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib87","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/WNL.20.6.545","article-title":"Pupil size and spontaneous pupillary waves associated with alertness, drowsiness, and sleep","volume":"20","author":"Yoss","year":"1970","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib88","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2165\/00003495-200464120-00003","article-title":"Management of fatigue in patients with multiple sclerosis","volume":"64","author":"Zifko","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2012.06.036_bib89","first-page":"983","article-title":"Modafinil in treatment of fatigue in multiple sclerosis \u2013 results of an open-label study","volume":"249","author":"Zifko","year":"2002","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.036_bib90","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1124\/jpet.108.146142","article-title":"Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil","volume":"329","author":"Zolkowska","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812002948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812002948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T10:54:06Z","timestamp":1617620046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812002948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":90,"alternative-id":["S0028390812002948"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.06.036","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}